The nature, degree, and kinetics of unscheduled thymidine incorporation previously shown to occur in 90% of irradiated lymphocytes was studied. The incorporation was severely depressed in the presence of 10-4 M acriflavine and by low temperature, but was unaffected by 10-3 M hydroxyurea or caffeine. Over a dose range of 25 to$400\ {\rm ergs}/{\rm mm}^{2}$, the uptake of thymidine was increased by a factor of only 1.6, although the survival of lymphocytes, measured 5 days after irradiation, decreased by almost two orders of magnitude. (The survival curve suggests that 90% of the lymphocytes have a$D_{0}\ \text{of}\ 35\ {\rm ergs}/{\rm mm}^{2}$ and 10% have a D0 of$250\ {\rm ergs}/{\rm mm}^{2}$.) After exposure to$25\ {\rm ergs}/{\rm mm}^{2}$, over 70% of the cells survived for 5 days in culture; moreover, cells which had been stimulated by this dose to incorporate thymidine transformed and divided after exposure to phytohemaglutinin. The final uptake of thymidine was significantly greater when a total dose of$75\ {\rm ergs}/{\rm mm}^{2}$ was fractionated into three doses of$25\ {\rm ergs}/{\rm mm}^{2}$ given at six hourly intervals than when it was given as a single dose. The degree of thymidine incorporation and the fraction of leukemic cells labeled were not significantly different from those in normal lymphocytes.
Skip Nav Destination
Close
Article navigation
1 November 1968
Research Article|
November 01 1968
Unscheduled Incorporation of Thymidine in Ultraviolet-Irradiated Human Lymphocytes
Radiat Res (1968) 36 (2): 287–298.
Citation
Richard G. Evans, Amos Norman; Unscheduled Incorporation of Thymidine in Ultraviolet-Irradiated Human Lymphocytes. Radiat Res 1 November 1968; 36 (2): 287–298. doi: https://doi.org/10.2307/3572653
Download citation file:
Close
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Sign in via your Institution
Sign in via your InstitutionCiting articles via
Commonalities Between COVID-19 and Radiation Injury
Carmen I. Rios, David R. Cassatt, Brynn A. Hollingsworth, Merriline M. Satyamitra, Yeabsera S. Tadesse, Lanyn P. Taliaferro, Thomas A. Winters, Andrea L. DiCarlo
Low-Dose Radiation Therapy (LDRT) for COVID-19: Benefits or Risks?
Pataje G. Prasanna, Gayle E. Woloschak, Andrea L. DiCarlo, Jeffrey C. Buchsbaum, Dörthe Schaue, Arnab Chakravarti, Francis A. Cucinotta, Silvia C. Formenti, Chandan Guha, Dale J. Hu, Mohammad K. Khan, David G. Kirsch, Sunil Krishnan, Wolfgang W. Leitner, Brian Marples, William McBride, Minesh P. Mehta, Shahin Rafii, Elad Sharon, Julie M. Sullivan, Ralph R. Weichselbaum, Mansoor M. Ahmed, Bhadrasain Vikram, C. Norman Coleman, Kathryn D. Held
Germicidal Efficacy and Mammalian Skin Safety of 222-nm UV Light
Manuela Buonanno, Brian Ponnaiya, David Welch, Milda Stanislauskas, Gerhard Randers-Pehrson, Lubomir Smilenov, Franklin D. Lowy, David M. Owens, David J. Brenner
Photon GRID Radiation Therapy: A Physics and Dosimetry White Paper from the Radiosurgery Society (RSS) GRID/LATTICE, Microbeam and FLASH Radiotherapy Working Group
Hualin Zhang, Xiaodong Wu, Xin Zhang, Sha X. Chang, Ali Megooni, Eric D. Donnelly, Mansoor M. Ahmed, Robert J. Griffin, James S. Welsh, Charles B. Simone, II, Nina A. Mayr